Logotype for Silk Road Medical Inc

Silk Road Medical (SILK) investor relations material

Silk Road Medical Q2 2024 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Silk Road Medical Inc
Q2 2024 earnings summary7 Aug, 2024

Executive summary

  • Revenue grew 13% year-over-year to $51.2 million for Q2 2024, driven by increased TCAR procedures and new product launches.

  • Gross margin improved to 75% from 71% year-over-year, benefiting from favorable purchase price variances and production efficiencies.

  • Net loss widened to $16.6 million ($0.42 per share) for Q2 2024, up from $13.5 million ($0.35 per share) in Q2 2023, primarily due to higher SG&A expenses.

  • Silk Road Medical entered into a definitive agreement to be acquired by Boston Scientific for $27.50 per share in cash, with the transaction expected to close in the second half of 2024.

  • Cash, cash equivalents, and investments totaled $186.2 million as of June 30, 2024.

Financial highlights

  • Q2 2024 revenue: $51.2 million, up 13% year-over-year; six-month revenue: $99.7 million, up 17%.

  • Gross profit for Q2 2024: $38.5 million (75% margin); six-month gross profit: $75.0 million (75% margin).

  • Operating loss for Q2 2024: $17.2 million; net loss: $16.6 million ($0.42 per share).

  • Operating expenses increased 20% year-over-year to $55.7 million, driven by higher R&D and SG&A costs.

  • Adjusted EBITDA loss narrowed to $1.1 million from $3.4 million in Q2 2023.

Outlook and guidance

  • Management expects continued revenue growth driven by increased TCAR adoption, new product launches, and international expansion.

  • Gross margin is expected to show modest improvement for full-year 2024 compared to 2023, despite inflationary and labor cost pressures.

  • The Boston Scientific acquisition is anticipated to close in the second half of 2024, subject to regulatory and stockholder approvals.

  • Prior full-year 2024 financial guidance withdrawn due to the proposed acquisition by Boston Scientific.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Silk Road Medical, Inc. is a medical device company that operates as a strategic niche player in its industry. The Company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization with devices under the Triangle MicroLaserTM and LaserCarotisTM brands, which include intracoronary stents, devices to deliver embolic protection during angiography, as well as other non-device related offerings intended to improve patient outcomes.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage